✦ LIBER ✦

YM155, a Novel Small-Molecule Survivin Suppressant, Combined With Radiation Therapy in Prostate Cancer Cell Lines

✍ Scribed by Thoms, J.; Aoki, S.

Book ID: 122186766
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 44 KB
Volume: 87
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2013.06.1716

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiosensitizing Effect of YM155, a Nove

Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell Lines

✍ Iwasa, T.; Okamoto, I.; Suzuki, M.; Nakahara, T.; Yamanaka, K.; Hatashita, E.; Y 📂 Article 📅 2008 🏛 American Association for Cancer Research 🌐 English ⚖ 741 KB

Broad spectrum and potent antitumor acti

Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models

✍ Takahito Nakahara; Aya Kita; Kentaro Yamanaka; Masamichi Mori; Nobuaki Amino; Ma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 653 KB

Population pharmacokinetic modeling of S

Population pharmacokinetic modeling of Sepantronium bromide (YM155), a small molecule survivin suppressant, in patients with non-small cell lung cancer, hormone refractory prostate cancer, or unresectable stage III or IV melanoma

✍ Yumiko Aoyama,Atsunori Kaibara,Akitsugu Takada… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 305 KB

P0224 A novel, small molecule inhibitor,

P0224 A novel, small molecule inhibitor, MSU-1001, in androgen-sensitive prostate cancer cell lines

✍ Bhavar, P.K.; Yadav, M.R.; Dinavahi, S.S.; Nyayapathy, S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 38 KB

RHEB, A NOVEL SMALL G-PROTEIN OF RAS SUP

RHEB, A NOVEL SMALL G-PROTEIN OF RAS SUPERFAMILY, IS ASSOCIATED WITH PROLIFERATION IN HUMAN PROSTATE CANCER CELL LINES

✍ T. Kobayashi; T. Inoue; Y. Shimizu; T. Segawa; T. Kamoto; O. Ogawa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A phase I/II study of Docetaxel (Taxoter

A phase I/II study of Docetaxel (Taxotere) combined with concurrent radiation therapy in locally advanced non-small cell lung cancer (NSCLC)

✍ Aamdal, S; Lauvvang, G; Owre, K; Hatlevoll, R; Armellini, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB